College of
Epidemiology 2000 Election

ACE President-Elect

RICHARD A. KASLOW, MD, MPH, is Professor of Epidemiology and International Health, Medicine and Microbiology at the University of Alabama at Birmingham.

BACKGROUND: Kaslow conducts research on genetic determinants in HIV/AIDS and other infectious diseases. Appointed in the Schools of Public Health and Medicine and as Co-Director of the Clinical Research Training Program, he teaches the principles and practice of population research. He received his M.D. and M.P.H. degrees from Harvard University and is board certified in internal medicine, infectious diseases and preventive medicine. He spent 8 years with the Centers for Disease Control and nearly 16 with the National Institute of Allergy and Infectious Diseases, primarily as Epidemiology and Biometry Branch Chief. He is a Fellow of the American College of Physicians and the Infectious Diseases Society of America as well as ACE, and a member of the Society for Epidemiologic Research and the American Epidemiological Society along with numerous other professional organizations. As an ACE Board member and subsequently, Kaslow has served in various committee and liaison assignments. He was Chair of the Epidemiology Section in the American Public Health Association. He has participated in various advisory and review committees for NIH, CDC, FDA and specialty certifying boards. Other past and current research interests include nosocomial infections, inflammatory and autoimmune diseases, Lyme disease, HIV/AIDS and other infections.

Board of Directors

AARON BLAIR, PH.D., M.P.H., is Chief of the Occupational Epidemiology Branch of the National Cancer Institute.

BACKGROUND: Blair has a Ph.D. in genetics from North Carolina State University and an M.P.H. in epidemiology from the University of North Carolina. He has been at the National Cancer Institute since 1976 and Chief of the occupational unit since 1980. His research as focused on the cancer risks among farmers and other groups exposed to pesticides, among workers exposed to organic solvents and other important industrial chemicals include formaldehyde and acrylonitrile, and methodologic issues in occupational epidemiology included procedures for developing quantitative exposure estimates and the impact of misclassification on risk estimates. Recently he has worked to encourage investigations of occupational exposures among women and among disadvantaged groups such as migrant farm workers. Blair has received the NIH Director’s Award, the PHS Special Recognition Award, and the H.A. Tyroler Distinguished Alumni Award from the UNC School of Public Health. He is a fellow in ACE and a member of the American Epidemiological Society. 

MARLENE B. GOLDMAN, Sc.D. is Principal Research Scientist and Director, Institute for Research on Women’s Health, New England Research Institutes

BACKGROUND: Goldman earned master’s and doctoral degrees in epidemiology from the Harvard School of Public Health. Prior to joining NERI, she was an Associate Professor of Epidemiology at Harvard where she taught epidemiologic principles and methods and developed a program in reproductive epidemiology. Trained as a chronic disease epidemiologist, she has twenty-eight years of experience in the design, conduct, and analysis of epidemiologic studies. Her research interests include the influence of environmental, occupational, and lifestyle factors on reproduction and the health consequences of exposure to ionizing radiation. Goldman designed and co-edited Women and Health, a 100-chapter epidemiology textbook on women’s health published by Academic Press. The book won the 1999 Award of Excellence in Medical Science from the Association of American Publishers. As an active member of ACE, she has been on the Program Planning Committee for the last two years and is a member of the Continuing Education Committee. From 1996 to 1999 she was an Epidemiology Section Councilor and is currently a Governing Councilor for APHA. Goldman is an associate editor of the American Journal of Epidemiology and a member of the American Society of Reproductive Medicine and the Society for Epidemiologic Research.

CAMARA PHYLLIS JONES, MD, MPH, PHD, is Assistant Professor of Health and Social Behavior and Epidemiology at the Harvard School of Public Health.

BACKGROUND: Jones is a methodologist and social epidemiologist whose work focuses on the impacts of racism on health. She received her B.A. in Molecular Biology from Wellesley College, her MD from the Stanford University School of Medicine, and her MPH and PhD in Epidemiology from the Johns Hopkins School of Hygiene and Public Health. She has completed residencies in both Family Practice and General Preventive Medicine. Jones' detailed analysis of systolic blood pressure by "race" suggests that the cardiovascular aging of black Americans is accelerated compared to that of white Americans by roughly ten years. She is developing explicit measures of racism to further explore the basis of this accelerated aging. Jones has also developed new statistical methods for simultaneously comparing the shapes, spreads, and locations of two distributions. These methods enable a population approach to data analysis in which the whole distribution, not simply the average value or the proportion of values beyond some threshold, becomes the object of study.
From January through September, 1999, Jones was based at the Ministry of Health in Wellington, New Zealand as an Ian Axford Fellow in Public Policy. There, she researched the question, "Maori-Pakeha Health Disparities: Can Treaty Settlements Reverse the Impacts of Racism?" Jones first served the American College of Epidemiology as a liaison from the Society for Epidemiologic Research to the College's Minority Affairs Committee. At the 1999 annual meeting of the College, Jones was one of the two plenary debaters speaking in favor of the motion, "Epidemiologists should engage in public health policy." Jones currently serves on the Board of Directors of both the Cambridge Public Health Commission and the National Black Women's Health Project.

CARLOS A. CAMARGO, MD, DrPH, is a Research Epidemiologist at the Channing Laboratory, Brigham and Women’s Hospital; Emergency Physician at the Massachusetts General Hospital; and Assistant Professor of Medicine at Harvard Medical School.

BACKGROUND: Dr Camargo’s interest in epidemiology began in college when he led several alcohol studies at the Stanford Center for Research in Disease Prevention. He later received an MPH in epidemiology from UC Berkeley, an MD from UC San Francisco, and did his residency at the Massachusetts General Hospital in Boston. He then did a research fellowship in cardiovascular epidemiology at the Brigham and Women’s Hospital, and earned a DrPH in epidemiology from the Harvard School of Public Health. Currently, Dr Camargo works clinically in an urban emergency department, and has focused his research on asthma/COPD. He serves as PI of the Multicenter Airway Research Collaboration (MARC), a network of >100 North American emergency departments ( MARC has provided unique data on asthma among minority populations, and led to the creation of a new network focusing on patient advocacy issues and how to increase timely access to primary care. Dr Camargo also is PI of several large cohort studies looking at risk factors for asthma/COPD in approximately 350,000 men and women. Dr Camargo’s work is funded by grants from the NIH, industry, and private foundations (e.g., EMF Center of Excellence Award). He is an active contributor to the scientific literature, editorial board member, and performs peer review for more than a dozen journals. He is a member of the Cochrane Collaboration, and the National Asthma Education and Prevention Program (NAEPP) Coordinating Committee.